Please assess the completion status of the following clinical trial:

Trial Title: Post Market Clinical Experience Study of Sientra 207 Breast Implants

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Is a candidate for primary or revision breast augmentation and is at least 22 years of age,~2. Agrees to Sientra study requirements and to comply with office follow-up visits at months 3, 6 and 12.~Exclusion Criteria:~1. Does not meet the Investigator's standard eligibility for breast augmentation or revision surgery~2. Surgeon is planning to use acellular dermal matrix (ADM) or surgical mesh and/or recommend postoperative massage.

- Gender: FEMALE
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Primary Augmentation (Type: None): Subjects undergoing general breast enlargement receiving Sientra Style 207 Silicone Gel Breast Implant.
- Revision Augmentation (Type: None): Subjects undergoing revision surgery with Sientra Style 207 Silicone Gel Breast Implant to revise or improve the result of a primary breast augmentation surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).